ES2185507B1 - PROCEDURE FOR OBTAINING AN ANTI-CELLULITE PRODUCT OF TOPICAL APPLICATION. - Google Patents

PROCEDURE FOR OBTAINING AN ANTI-CELLULITE PRODUCT OF TOPICAL APPLICATION.

Info

Publication number
ES2185507B1
ES2185507B1 ES200102233A ES200102233A ES2185507B1 ES 2185507 B1 ES2185507 B1 ES 2185507B1 ES 200102233 A ES200102233 A ES 200102233A ES 200102233 A ES200102233 A ES 200102233A ES 2185507 B1 ES2185507 B1 ES 2185507B1
Authority
ES
Spain
Prior art keywords
procedure
obtaining
topical application
cellulite product
cellulite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES200102233A
Other languages
Spanish (es)
Other versions
ES2185507A1 (en
Inventor
Pedro Tocabens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Acta Farma S L L
Acta Farma Sll
Original Assignee
Acta Farma S L L
Acta Farma Sll
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acta Farma S L L, Acta Farma Sll filed Critical Acta Farma S L L
Priority to ES200102233A priority Critical patent/ES2185507B1/en
Publication of ES2185507A1 publication Critical patent/ES2185507A1/en
Application granted granted Critical
Publication of ES2185507B1 publication Critical patent/ES2185507B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Procedimiento para la obtención de un producto anticelulítico de aplicación tópica, que consiste en una composición formada por principios activos formados por Yodo orgánico del tipo de Iodhidrato de trietanolamina, cafeína, Humulus lupulus, Equisetum arvense, Ruscus aculeatus y Centella asiática, incorporándose aditivos o excipientes.Procedure for obtaining a topical application anti-cellulite product, which consists of a composition formed by active principles formed by organic iodine of the type of triethanolamine hydrochloride, caffeine, Humulus lupulus, Equisetum arvense, Ruscus aculeatus and Centella asiatica, incorporating additives or excipients .

ES200102233A 2001-10-05 2001-10-05 PROCEDURE FOR OBTAINING AN ANTI-CELLULITE PRODUCT OF TOPICAL APPLICATION. Expired - Fee Related ES2185507B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES200102233A ES2185507B1 (en) 2001-10-05 2001-10-05 PROCEDURE FOR OBTAINING AN ANTI-CELLULITE PRODUCT OF TOPICAL APPLICATION.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200102233A ES2185507B1 (en) 2001-10-05 2001-10-05 PROCEDURE FOR OBTAINING AN ANTI-CELLULITE PRODUCT OF TOPICAL APPLICATION.

Publications (2)

Publication Number Publication Date
ES2185507A1 ES2185507A1 (en) 2003-04-16
ES2185507B1 true ES2185507B1 (en) 2004-08-01

Family

ID=8499118

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200102233A Expired - Fee Related ES2185507B1 (en) 2001-10-05 2001-10-05 PROCEDURE FOR OBTAINING AN ANTI-CELLULITE PRODUCT OF TOPICAL APPLICATION.

Country Status (1)

Country Link
ES (1) ES2185507B1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2049661B1 (en) * 1992-10-09 1994-11-01 Imbeal S A Lab ANTI-CELLULITE COMPOUND AND PROCEDURE FOR OBTAINING THE SAME.
ES2077827T3 (en) * 1990-11-28 1995-12-01 Oreal SLIMMING COMPOSITION BASED ON GINKGO BILOBA AS ALPHA-2-BLOCKERS.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU76148A1 (en) * 1976-11-08 1978-07-10

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2077827T3 (en) * 1990-11-28 1995-12-01 Oreal SLIMMING COMPOSITION BASED ON GINKGO BILOBA AS ALPHA-2-BLOCKERS.
ES2049661B1 (en) * 1992-10-09 1994-11-01 Imbeal S A Lab ANTI-CELLULITE COMPOUND AND PROCEDURE FOR OBTAINING THE SAME.

Also Published As

Publication number Publication date
ES2185507A1 (en) 2003-04-16

Similar Documents

Publication Publication Date Title
MY146247A (en) Solid pharmaceutical dosage form comprising ritonavir
BR9803198A (en) Compound, processes to prepare the same and to combat fungus or a fungal plant disease in one place, and, composition.
AU9163701A (en) Topical composition containing at least one vitamin D or one vitamin D analogue and at least one corticosteroid
MXPA02011303A (en) Liquid pharmaceutical composition containing an erythropoietin derivate.
PA8576201A1 (en) PHARMACEUTICAL COMPOSITION THAT HAS A DISTRIBUTION AND UNIFORM POWER OF FARMACO
BR0312573A (en) Phenyl- [4- (3-phenyl-1h-pyrazol-4-yl) -pyrimidin-2-yl] -amine derivatives
TW200700406A (en) Novel thiophene derivatives
BR0211905A (en) Rapamycin dialdehydes
TW200716591A (en) Novel thiophene derivatives
GT199900203A (en) CELECOXIB COMPOSITIONS.
MX2022001719A (en) Formulations of benzazepine conjugates and uses thereof.
GB0421900D0 (en) Inhibition of tumour cell migration
AR082579A2 (en) A PHARMACEUTICAL COMPOSITION SPONTANEALLY AVAILABLE FOR ORAL ADMINISTRATION, USE FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF CANCER, METHOD FOR INCREASING BIODISPONIBILITY LEVELS OR REDUCING ITS VARIABILITY
BRPI0620436B8 (en) modified lysine mimetic compounds, pharmaceutical composition and usage
PA8509001A1 (en) DOSAGE FORM OF DRUGS DRIVEN BY A HYDROGEL
TW200738670A (en) Novel thiophene derivatives
AR032204A1 (en) CYCLODEXTRINE-DROSPIRENONE INCLUSION COMPLEXES
BRPI0508125A (en) alkaloid formulation, method for improving the effectiveness of an alkaloid, use of the reaction product of one or more alkaloids with one or more phosphate derivatives of one or more electron transfer agents, together with excipients and pharmaceutical composition
PY0206703A (en) METHOD FOR MANUFACTURING A LOW-DOSE PHARMACEUTICAL COMPOSITION HAVING UNIFORM DRUG DISTRIBUTION AND POTENCY
CO5050328A1 (en) SOLVENT SYSTEM FOR THE BEST PENETRATION OF PHARMACEUTICAL COMPOUNDS
UY27275A1 (en) COMPOSITIONS AND METHODS TO INCREASE THE BIODISPONIBILITY OF PHARMACEUTICAL AGENTS
ES2068797T1 (en) HAIR TREATMENT PRODUCT AND PROCEDURE FOR ITS APPLICATION.
BR0013106A (en) Floating pharmaceutical composition, tablet, and tablet preparation process.
AR039232A1 (en) A PHARMACEUTICAL FORMULATION THAT INCLUDES AT LEAST A SELECTED COMPOSITE OF THE GROUP FORMED BY NON-BARBITURIC HYPNOTICS AND NON-BENZODIACEPINICS, AND MELATONIN
ES2164527B1 (en) PROCEDURE FOR OBTAINING GABAPENTINA OF PHARMACEUTICAL QUALITY.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20030416

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2185507B1

Country of ref document: ES

FD1A Patent lapsed

Effective date: 20100312